Experience

Nutriband Inc.

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Chief Operating Officer, Nutriband and President, 4P Therapeutics Subsidiary

  • Dec 2018 - Present

• Head of 4P Therapeutics Subsidiary; Head of Clinical, Regulatory, Quality Nutriband

  • Aug 2018 - Dec 2018

  Nutriband is a publicly traded company (OTC: NTRB) focused on developing transdermal products



Expert Opinion on Drug Delivery

• Editorial Board Member

  • Jan 2004 - Present

  International journal publishing rigorously peer-reviewed review articles in drug delivery research from initial concept to potential therapeutic application and clinical use. International journal publishing rigorously peer-reviewed review articles in drug delivery research from initial concept to potential therapeutic application and clinical use.



4P Therapeutics

• Co-Founder & Chief Operating Officer

  • Oct 2017 - Jul 2018

• Vice President, Clinical, Regulatory, & Operations and Co-founder

  • Oct 2011 - Sep 2017

  Start-up focused on novel transdermal delivery research and development



Altea Therapeutics

• Israel
• Pharmaceutical Manufacturing

• Vice President, Product Development

  • Mar 2004 - Oct 2011

  Head of Clinical R&D, Regulatory Affairs, Project Management and Operations. Led development programs with pharma partners: Eli Lilly, Amylin, and Hospira.

• Vice President, Pharmaceutical Sciences

  • Feb 2003 - Feb 2004

  Head of Pharmaceutical Sciences responsible for preclinical, clinical research, formulation, analytical, bioanalytical and drug/vaccine delivery groups.

• Vice President of Research

  • Nov 2001 - Jan 2003

  Led R&D programs with pharma partners Elan and Novartis.

• Director of Research

  • Jun 2001 - Oct 2001

  Led R&D efforts for a startup novel transdermal technology company focusing on delivery of macromolecules through the skin.

• Senior Scientist

  • Mar 2000 - Jun 2001



SpectRx

• Medical Equipment Manufacturing

• Senior Research Scientist

  • Feb 1997 - Mar 2000

  SpectRx IPO July 1997 (Nasdaq SPRX) SpectRx became Guided Therapeutics Feb 2008 (Nasdaq GTHP.OB) http://www.guidedinc.com/ SpectRx IPO July 1997 (Nasdaq SPRX) SpectRx became Guided Therapeutics Feb 2008 (Nasdaq GTHP.OB) http://www.guidedinc.com/



Ackrad Labs and Rutgers University

• Research Engineer

  • 1991 - 1996

  Ackrad Labs acquired by Cooper Surgical May 2002 http://www.coopersurgical.com/aboutus/Pages/Profile.aspx Ackrad Labs acquired by Cooper Surgical May 2002 http://www.coopersurgical.com/aboutus/Pages/Profile.aspx



Rutgers University

• United States
• Higher Education
• 700 & Above Employee

• Research Scientist - Dept of Biomedical Engineering

  • 1988 - 1990

  Rutgers Biomedical Engineering Department formed 1986. http://biomedical.rutgers.edu/content/intro.php Rutgers Biomedical Engineering Department formed 1986. http://biomedical.rutgers.edu/content/intro.php